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Genetic studies in fish, amphibia, and mice have shown that deficiency of Nodal signaling blocks differentiation into mesoderm and
endoderm. Thus, Nodal is considered as a major inducer of mesendoderm during gastrulation. On this basis, Nodal is a candidate for
controlling differentiation of pluripotent human embryonic stem cells (hESCs) into tissue lineages with potential clinical value. We have
investigated the effect of Nodal, both as a recombinant protein and as a constitutively expressed transgene, on differentiation of hESCs. When
control hESCs were grown in chemically defined medium, their expression of markers of pluripotency progressively decreased, while
expression of neuroectoderm markers was strongly upregulated, thus revealing a neuroectodermal default mechanism for differentiation in
this system. hESCs cultured in recombinant Nodal, by contrast, showed prolonged expression of pluripotency marker genes and reduced
induction of neuroectoderm markers. These Nodal effects were accentuated in hESCs expressing a Nodal transgene, with striking
morphogenetic consequences. Nodal-expressing hESCs developing as embryoid bodies contained an outer layer of visceral endoderm-like
cells surrounding an inner layer of epiblast-like cells, each layer having distinct gene expression patterns. Markers of neuroectoderm were not
upregulated during development of Nodal-expressing embryoid bodies, nor was there induction of markers for definitive mesoderm or
endoderm differentiation. Moreover, the inner layer expressed markers of pluripotency, characteristic of undifferentiated hESCs and of
epiblast in mouse embryos. These results could be accounted for by an inhibitory effect of Nodal-induced visceral endoderm on pluripotent
cell differentiation into mesoderm and endoderm, with a concomitant inhibition of neuroectoderm differentiation by Nodal itself. There could
also be a direct effect of Nodal in the maintenance of pluripotency. In summary, analysis of the Nodal-expressing phenotype suggests a
function for the transforming growth factor-beta (TGF-h) growth factor superfamily in pluripotency and in early cell fate decisions leading to
primary tissue layers during in vitro development of pluripotent human stem cells. The effects of Nodal on early differentiation illustrate how
hESCs can augment mouse embryos as a model for analyzing mechanisms of early mammalian development.
D 2004 Elsevier Inc. All rights reserved.
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Human embryonic stem cells (hESCs) are pluripotent
cells derived from embryos cultured from the blastocyst
stage (Thomson et al., 1998). Their embryonic origin
confers upon hESCs the capacity to differentiate into the0012-1606/$ - see front matter D 2004 Elsevier Inc. All rights reserved.
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E-mail address: lv225@cam.ac.uk (L. Vallier).three primary germ layers as well as extraembryonic tissues
(Xu et al., 2002). This property of pluripotency is
maintained even after prolonged periods of in vitro culture.
hESCs also have a prolonged proliferative capacity and
genetic stability that is unique for cultured human cells
(Amit et al., 2000). These characteristics confer an excep-
tional value on hESCs for regenerative medicine. Robust
technologies for enhancing and diminishing gene function
in hESCs are now becoming available to expedite their
controlled in vitro differentiation into specific, clinically
valuable cell types (Vallier et al., 2004). Beyond this275 (2004) 403–421
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unique in vitro system for modeling early human develop-
ment at stages, such as gastrulation, that have heretofore
been studied only in laboratory mammals.
The first event of gastrulation in mouse is the formation
of the primitive streak (Lu et al., 2001). This distinct
morphological structure marks the posterior pole of the
embryo’s anteroposterior (A–P) axis and also generates
mesendoderm, the source of definitive mesoderm and
endoderm. Recent studies have revealed that extraem-
bryonic tissues are essential for A–P patterning. Visceral
endoderm (VE) in particular is involved in the establish-
ment, localization, and orientation of the anterior pole of the
A–P axis (Kalantry et al., 2001; Kimura et al., 2000).
Specifically, the anterior visceral endoderm (AVE) is
essential for correct development of the trunk and head
(Hallonet et al., 2002; Perea-Gomez et al., 2001a; Varlet et
al., 1997). Although understanding of the molecular basis of
A–P patterning in mammalian development is still limited,
initial studies have revealed a key role of the transforming
growth factor-beta (TGF-h) growth factor superfamily
member, Nodal.
Genetic studies have shown that disruption of Nodal
signaling in mouse embryonic development inhibits prim-
itive streak formation (Conlon et al., 1994; Zhou et al.,
1993) and blocks AVE maturation (Robertson et al., 2003).
Like other TGF-h superfamily members, Nodal binds to
heteromeric complexes between type I (Alk4 and Alk7) and
type II (ActRIIB) Activin receptors, which in turn act
through the Smad2/Smad3 signaling pathway (reviewed in
Schier, 2003). Nodal signaling is also regulated by Cripto,
an extracellular GPI-linked protein which acts as a cofactor,
and by antagonists, the best studied of which are Lefty1 and
Cerberus. These antagonists are expressed during gastrula-
tion in the AVE and in anterior definitive endoderm (ADE),
where they act to diminish Nodal activity in the embryo’s
anterior, thus preserving this region for head development
(Perea-Gomez et al., 2001b). The abnormalities of mouse
Nodal mutants at the early primitive streak and subsequent
stages emphasize the importance of this genetic pathway in
early mammalian development, a role that has been
generalized to vertebrates in Xenopus and zebrafish studies
(reviewed in Schier, 2003). Thus, the essential functions of
Nodal signaling in the differentiation of the primary germ
layers and in A–P patterning seem to be evolutionary
conserved.
The key function of Nodal in mesoderm and endoderm
differentiation would appear to designate it as a candidate to
drive in vitro differentiation of hESCs into these primary
germ layers, which are particularly attractive for clinical
application as sources of potentially transplantable cell
types. We therefore investigated the function of Nodal
signaling during hESC differentiation by adding recombi-
nant Nodal or by overexpressing the Nodal gene. We found
that, rather than inducing differentiation of hESCs into the
mesoderm and endoderm primary germ layers, Nodalinhibited progression along the neuroectoderm default
pathway of neuroectoderm while promoting the differ-
entiation of extraembryonic visceral endoderm and main-
taining the expression of markers of pluripotency.Materials and methods
hESC culture and transfection
H9 hES cells (WiCell, Madison, WI) were cultured as
described (Thomson et al., 1998) in KSR medium contain-
ing KO-DMEM supplemented with Serum Replacement
(Invitrogen). Every 4 days, cells were harvested using 1 mg/
ml collagenase IV (Gibco) and then plated into 60-mm
plates (Costar) precoated with 0.1% porcine gelatin (Sigma)
and containing 1  105 irradiated mouse embryonic
fibroblasts. For stable transfection with vectors encoding
mouse Nodal or NodalGFP, three confluent 60-mm plates
containing around 2000 hES colonies each were plated onto
one six-well gelatin-coated plate containing 5  104 feeders.
After 48 h, the cells were transfected using Lipofectamine
2000 (Invitrogen) as described (Vallier et al., 2004). Three
days after transfection, the cells were passed onto 60-mm
gelatin-coated tissue-culture plates containing puromycin-
resistant mouse fetal fibroblasts as feeders. After 3 addi-
tional days, puromycin (1 Ag/ml final concentration) was
added. Puromycin-resistant colonies that appeared by 12
days of selection were picked, dissociated, and plated onto
24-well gelatin-coated, feeder-containing plates, and
expanded for further analysis as described above.
hESC differentiation was induced by embryoid body
(EB) formation. This was accomplished by incubating
colonies in medium containing 1 mg/ml collagenase IV
without FGF for 6 h, after which all the colonies (but not
feeders cells) had detached from the plate. The colonies
were then rinsed once in the corresponding medium to be
used for differentiation (below) and grown in nonadherent
conditions to generate EBs. The composition of the medium
used for differentiation was either (1) KO-DMEM supple-
mented by 10% fetal bovine serum (FBS; Hyclone), (2) KO-
DMEM supplemented by 20% Serum Replacer (Gibco), or
(3) chemically defined medium (CDM) (Johansson and
Wiles, 1995) consisting of 50% IMDM (Gibco) plus 50%
F12 NUT-MIX (Gibco), supplemented with 7 Ag/ml of
insulin (Roche), 15 Ag/ml of transferrin (Roche), 450 AM of
monothioglycerol (Sigma), and 5 mg/ml albumin fraction V
(Sigma). The effect of Nodal on EB growth was assayed by
adding 50 ng/ml of mouse recombinant Nodal (R&D
systems).
To obtain outgrowths of Nodal-expressing EBs in
adherent conditions, they were plated in six-well plates after
10 days of differentiation as EBs. To allow EB adhesion in
CDM, plates were precoated with FBS for 24 h at 378C and
then washed twice in PBS to eliminate any serum. Plated
EBs were then grown for 20 additional days in CDM.
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cells at various passages. Abnormalities involving chromo-
somes 9, 5, and 19 were observed at late passages (p80–
p115) confirming recent results suggesting that hESCs are
susceptible to genetic instability (Draper et al., 2004).
Consequently, only hESCs from earlier passages (p50–
p70) were used for these experiments. Nodal-expressing
clones were found to have a normal karyotype during at
least 15 passages after subcloning.
Flow cytometry
NodalGFP-overexpressing hESCs were dissociated with
trypsin (0.25%) plus EDTA (1 mM; Gibco), washed once in
medium containing fetal calf serum (PAA), and washed
twice in PBS containing 0.1% serum (hES). The cells were
then immediately analyzed on a FACSCalibur flow cytom-
eter (Becton Dickson) using Cellquest acquisition and
analysis software (Becton Dickson).
For detection of SSEA-4, adherent cells were washed
twice in PBS then incubated for 20 min at 378C in cell
dissociation buffer (Invitrogen). Cells were then dissociated
by gentle pipetting and resuspended at approximately 0.1
to 1.0  105 cells/ml in PBS + 3% normal goat serum
containing 0.1% azide (NGS) (Serotec). Cells were
incubated for 20 min at 48C with SSEA-4 antibody (clone
MC813, 1:200, Developmental Studies Hybridoma Bank)
or the corresponding isotype control (mouse IgG isotype
control, Pharmingen). Cells were then washed twice in
PBS + 3% NGS and incubated for 20 min on ice with an
fluorescein isothiocyanate (FITC)-conjugated goat anti-
mouse IgG antibody (1:250, Sigma) and subsequently
resuspended in PBS + 3% NGS for stained with 7-
aminoactinomycin D (7-AAD) viability dye (Immunotech)
at 20 Al/ml for 15 min at room temperature. Live cells
identified by 7-AAD exclusion were analyzed for surface-
marker expression using FACSCalibur.
Transcriptional response assay
DNA plasmids including the pAR3-lux firefly luciferase
reporter and CMV-Renilla (Promega) were cotransfected
into hESCs to assess their transcriptional response to
exogenous Nodal. The ratio between pAR3-lux and CMV-
Renilla was 10:1. recNodal or supernatant of Nodal-over-
expressing hESCs (collected after 24 h of culture) was
added 18 h after pAR3-lux transfection. Cells were
harvested 48 h later for luciferase essay. Luciferase activity
was measured using the dual luciferase assay in cell lysates
as described (Promega). Firefly luciferase activity was
normalized to Renilla luciferase activity.
RNA extraction and RT–PCR
Total RNAs were extracted from hESCs or EBs using the
RNeasy Mini Kit and RNeasy Microkit for dissected EBlayers (Qiagen). Each sample was treated with RNAse-Free
DNAse (Qiagen) to avoid DNA contamination. A test PCR
was done on all the RNA samples to verify the absence of
genomic contamination. For each sample, 0.5 Ag of total
RNA was reverse-transcribed using Superscript II Reverse
Transcriptase (Invitrogen). PCR reaction mixtures were
prepared as described (Promega protocol for Taq polymer-
ase) then were denatured at 948C for 5 min and cycled at
948C for 30 s, 50–658C for 30 s, and 728C for 30 s followed
by final extension at 728C for 10 min after completion of 40
cycles. Primer sequences, annealing temperatures, and their
expected products are described in Supplementary Table 1.
All the PCR reactions were done with a negative control
containing only water and a positive control containing
RNA extracted from EBs grown for 30 days in FBS-
supplemented medium (data not shown). The expression of
the beta2 microglobulin (h2M) housekeeping gene was used
to normalize PCR reactions.
Immunofluorescence and histology
hESCs or their differentiated derivatives were fixed for
20 min at 48C in 4% paraformaldehyde (PFA) and then
washed three times in PBS. Cells were incubated for 20 min
at room temperature in PBS containing 10% goat serum
(Serotec) and subsequently incubated for 2 h at room
temperature with primary antibody diluted in 1% goat serum
in PBS as follows: SSEA-1 (clone MC480, 1:50, Devel-
opmental Studies Hybridoma Bank), SSEA-4 (clone
MC813, 1:50, Developmental Studies Hybridoma Bank),
Tra-1-60 (Chemicon International, 1:20), Oct-4 (SantaCruz,
1:100), and alphafetoprotein (aFP, R&D systems, 1:200).
Cells were then washed three times in PBS and incubated
with fluorescein isothiocyanate-conjugated antimouse IgG
or IgM (Sigma 1:200 in 1% goat serum in PBS) for 2 h at
room temperature. Unbound secondary antibody was
removed by three washes in PBS. Hoechst 33258 was
added to the first wash (Sigma 1:10,000).
For cryosectioning, EBs were fixed overnight at 48C in
PBS with 4% PFA and then incubated overnight in PBS
with 30% sucrose. After freezing on dry ice in Tissue-Tek
OCT medium (Sakura), EBs were sectioned at 5–7 Am,
deposited on polylysine-coated slides, and stored at 48C.
Slides were postfixed in PBS containing 4% PFA for 20 min
on ice. Immunostaining was performed following the same
procedure used for plated cells (above). Secondary antibody
was Cy3-conjugated donkey antimouse (Chemicon Interna-
tional, 1:500). Specimens were mounted in Pro-Long
antifade medium (Molecular Probes).
In situ hybridization
In situ hybridization (ISH) of hESC colonies and EBs
was performed using the method described by Streit and
Stern (2001). Antisense and sense probes for Oct-4, HNF3b,
Brachyury, Cerberus, Nodal, and H19 were synthesized
L. Vallier et al. / Developmental Biology 275 (2004) 403–421406using the DIG RNA labeling kit form Roche. Each probe
was generated by subcloning PCR fragments synthesized
using the corresponding primers (see Supplementary Table
1) in the Topo cloning PCRII vector (Invitrogen).Results
hES cells and their differentiated derivatives express
components of the Nodal pathway
We first tested expression of Nodal signaling components
and pluripotency markers in hESCs using semiquantitative
RT–PCR (Fig. 1A). This assessment detected Nodal, Cripto,
ActRIIB, and Alk4, components of the Nodal signaling
pathway, as well as Oct-4 and FGF4, two markers of
pluripotency (Avilion et al., 2003). Nodal expression in
hESCs was confirmed by in situ hybridization (ISH) (Fig.
1B). We then tested expression of these genes during
differentiation of hESCs into embryoid bodies (EBs) (Fig.
1A). Nodal and Cripto transcripts disappeared after 6 days
of differentiation, this coinciding with the loss of transcripts
for Oct-4 and FGF4. Nodal receptor (Alk4, ActRIIB)
expression was maintained during this period of differ-
entiation. These results are consistent with previous data
showing expression of different TGFh pathway components
in hESCs and during differentiation (Brandenberger et al.,
2004; Brivanlou et al., 2003; Ginis et al., 2004; Schuldiner
et al., 2000; Zeng et al., 2004). The expression of Nodal and
its receptors implicates the Nodal signaling pathway as aFig. 1. Expression of markers of pluripotency, gastrulation, and the Nodal pat
pluripotency markers and Nodal pathway components in hESCs (box, left) and
medium on a feeder layer (see Materials and methods). Differentiation was induce
FBS, medium containing 10% fetal bovine serum; SR, medium containing 20%
serum replacer. RNAs were extracted every 2 or 3 days for 2 weeks (D2–D14), and
denoted. (B) Examination of pluripotency (Oct-4) and gastrulation markers Brachy
using in situ hybridization (ISH). Sense probes were used as negative controls. Spotential factor involved in regulating the development of
hESCs and their differentiated derivatives.
As a basis for determining the role of Nodal in hESC
development, we examined the effect of growth media
supplemented with protein components of varying complex-
ities. No major differences in the expression of Nodal
pathway components were observed between media con-
taining fetal bovine serum (FBS), serum replacer (SR), or
neither of these (chemically defined medium, CDM)
(Johansson and Wiles, 1995). Therefore, we elected to use
CDM in the remaining experiments to avoid the presence of
unknown factors that could interfere with the Nodal
signaling pathway.
The expression of markers representative of the definitive
germ layers (ectoderm, mesoderm, and endoderm) was also
studied to evaluate the capacity of hESCs for differentiation
in this system. Markers of the neuroectoderm lineage,
including Pax6, MAP2, Sox1, Sox2, Musashi, Hesx1,
Nestin, and Neurod1 were all expressed in EBs grown in
CDM (Fig. 2B and data not shown). Markers of mesoderm
differentiation, including Myf5 and MyoD (reviewed in
Parker et al., 2003), were detected but only transiently (Fig.
2B), suggesting that CDM alone was permissive but not
inductive of definitive mesoderm differentiation. Previous
data predict such a response to CDM, since addition of
BMP4 or Activin was required to induce mesoderm differ-
entiation of mouse ES cells in CDM (Wiles and Johansson,
1999). There was no expression of the definitive endoderm
marker intestinal fatty acid binding protein (IFABP) (Fig.
2B) (Wells and Melton, 2000). However, expression ofhway in hESCs and their differentiated derivatives. (A) Examination of
during differentiation using RT–PCR. hESCs were initially grown in KSR
d by growing hESCs as EBs for varying times using three different media.
serum replacer; and CDM, medium containing BSA, but without serum or
then RT–PCR analysis was performed to detect the expression of the genes
ury (Bra), Foxa2, and Cerberus (Cer) plus Nodal in undifferentiated hESCs
cale bar: 200 Am.
Fig. 2. Effect of recNodal on hESCs differentiation. (A) EBs grown for 10
days in the absence (hEB D10, upper left panel) or presence of recNodal
(hEB D10 + recNodal, upper right panel). The lower left panel illustrates at
higher magnification a typical EB obtained in CDM. The lower right panel
illustrates at higher magnification an embryoid body developing in
recNodal. EBs grown in the presence of recNodal frequently contained
hollow and distended vesicles (indicated by red arrowheads in upper right
panel). Scale bar: 200 Am. (B) Expression of pluripotency and differ-
entiation markers during differentiation of hESCs in the absence or
presence of recNodal. RNAs were extracted every 2 days during 14 days
(D2–D14), and then RT–PCR analysis was performed to detect the
expression of the genes denoted. EBs differentiated for 30 days in medium
containing serum were used as positive control (Pos).
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protein (aFP) (Fig. 2B) and GATA4 (data not shown)
(Krumlauf et al., 1985; Narita et al., 1997), was observed,
suggesting that CDM is permissive for differentiation of
hESCs into a component of the primitive endoderm lineage.
Taken together, these results suggest that growing hESCs in
CDM in the absence of the growth factors provided by
complex protein mixtures favors differentiation into the
definitive neuroectodermal but not the definitive mesoder-
mal or endodermal lineages. This finding is therefore
consistent with the neuroectoderm default model that has
been described for the Xenopus embryo and postulated to
exist in embryonic stem cells (Parisi et al., 2003; Tropepe et
al., 2001; reviewed in Munoz-Sanjuan and Brivanlou,
2002).We also examined hESC colonies for their expression of
early markers of gastrulation, including Brachyury (Bra),
Foxa-2 (HNF3h), and Cerberus (Cer). Surprisingly, we
detected the expression of these three genes in undiffer-
entiated hESCs by RT–PCR (data not shown). The
distribution of transcripts was further examined using in
situ hybridization (Fig. 1B). Similarly to Nodal, Bra and
Foxa-2 transcripts were detected in all the colonies (the
expression of the corresponding proteins was not inves-
tigated due to the unavailability of the respective anti-
bodies). In the same cultures, Oct-4 displayed a similar
pattern of ubiquitous expression. By contrast, Cer expres-
sion was limited to a small number of cells scattered
throughout a fraction of the colonies. These results revealed
that transcription of genes commonly used to study
gastrulation in mouse embryos could not be used as markers
for hESC differentiation. Therefore, we selected markers for
gastrulation and primary germ layer differentiation that were
not expressed in hESCs. These consisted of Neurod1 for
neuroectoderm differentiation (Breslin et al., 2003), MyoD
and Myf5 for mesoderm differentiation, IFABP for defin-
itive endoderm differentiation, and aFP for extraembryonic
endoderm differentiation.
Recombinant Nodal modulates differentiation of hESCs
grown as embryoid bodies
We first determined the effect of Nodal as an inducer of
hESC differentiation by adding recombinant Nodal (recNo-
dal) to colonies in monolayer cultures. After 6 days in
recNodal (50 ng/ml), colony morphology was normal (data
not shown), with no additional differentiation observed as
compared to untreated cells. Consistent with this, addition
of recNodal led neither to decreased expression of Oct-4 or
FGF4 nor to increased expression of NeuroD1, MyoD, or
aFP (data not shown).
We next analyzed the Nodal effect on differentiation by
adding recombinant Nodal to hESCs cultured as embryoid
bodies. Control EBs generated from hESCs grown in CDM
were typically round, homogenous, and compact (Fig. 2A).
By contrast, EBs developing in CDM containing recNodal
(50 ng/ml) acquired a cystic morphology (Fig. 2A).
Expression of pluripotency and differentiation markers
was analyzed by semiquantitative RT–PCR every 2 days
during 2 weeks of culture (Fig. 2B). Expression of Oct-4,
Cripto, and endogenous Nodal persisted in EBs grown in
the presence of recombinant Nodal. Despite the Nodal-
induced persistence of expression for these markers of
pluripotency, expression of the neuronal marker Neurod1
was also detected, and expression of FGF4 (a marker of
pluripotency that is sensitive to differentiation-induced
silencing; our unpublished observations) disappeared within
1 week. However, expression of the definitive mesoderm
(MyoD and Myf5, Fig. 2B) and endoderm markers (IFABP,
Fig. 2B) was not seen in cultures containing recNodal,
although they did appear in controls. Expression of the
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induced in both Nodal-treated and control EBs, suggesting
that extraembryonic endoderm differentiation was occurring
in both conditions. Taken together, these gene expression
findings indicate that recombinant Nodal modulates the
differentiation of hESCs grown as EBs. However, EBs are
compact aggregates of cells and have epithelial differ-
entiation of their outer cells. Consequently, the internal
diffusion of exogenously added growth factor is likely to be
limited, and this could account for the diversity of molecular
features (expression of both pluripotency and differentiation
markers) noted during EB development accompanying
treatment with recNodal.
Generation of Nodal-overexpressing hESC lines
To overcome the limitations of exogenously added
growth factors, we undertook to overexpress Nodal stably
in hESCs, using an approach we had developed for such
purposes (Vallier et al., 2004). Secretion and maturation of
Nodal protein involve proteolytic processing (Constam and
Robertson, 1999). Accordingly, we used not only the native
Nodal coding sequence (NHN), but also a modified version
in which the native proregion was replaced by the BMP 2/4
proregion (BHN, Fig. 3A), which is known to be processed
effectively in a large number of cell types (Dale et al., 1993;
Thomsen and Melton, 1993). Finally, to enable an easy
monitoring of Nodal protein expression, we alternatively
used a fusion gene between mouse Nodal cDNA and the
green fluorescent reporter gene (NodalGFP) (Sakuma et al.,
2002). Briefly, mouse Nodal cDNAs (NHN, BHN, or
NodalGFP, Fig. 3A) were subcloned into the pTP6
expression vector (Pratt et al., 2000), and the resulting
constructs were transfected in both H9 and hSF-6 hES cell
lines. Colonies generated using the NHNpTP6 vector (N =
25 for H9 cell line and N = 8 for hSF-6 cell line) and the
BHNpTP6 vector (N = 5 for H9 cell line and N = 8 for hSF-
6 cell line) were screened for Nodal expression using
semiquantitative PCR with primers that distinguished the
mouse Nodal cDNA from its human counterpart (Fig. 3B).
Colonies generated using the NodalGFPpTP6 (N = 15 for
hSF-6) were screened using FACS to allow a quantitative
and qualitative evaluation of NodalGFP protein expression
(Fig. 4B). These analyses showed clear evidence of NodalFig. 3. Effect of Nodal overexpression on hESCs. (A) Map of the NHNpTP6 and B
Nodal cDNA and an IRES puromycin resistance gene allowing strong selecti
Expression of mouse Nodal in H9 sublines generated by transfection of HNHpTP6
green fluorescent protein (hrGFP2) and nontransfected hESCs were used as nega
RecNodal and supernatant of Nodal-expressing hESCS cells activate the pAR3-lu
After transfection, cells were incubated 48 h in the absence (Neg) or presence of
Nodal-overexpressing hESC line (SupNHN4). Normalized luciferase activity is
Expression of pluripotent stem cell markers by wild-type H9 cells and Nodal-ex
wild-type cells and in Nodal-expressing cells by immunofluorescence. White ar
frequently seen in wild-type colonies but absent from those expressing Nodal. Su
(green fluorescence) showing the specificity of these markers. Scale bar: 200 Amprotein expression and also revealed important variations in
its level between different cell lines. We then established a
reporter assay for Nodal signaling activity to evaluate its
proper secretion. H9 cells incubated with RecNodal or with
supernatant from Nodal-overexpressing hESC cell lines
were transitorily transfected with the pAR3-lux reporter,
which contains an Activin response element from the
Xenopus Mix.2 gene (Hayashi et al., 1997). The pAR3-
lux reporter plasmid has previously been shown to be
inducible by Nodal and Activin in embryonal carcinoma
cells (Kumar et al., 2001). Incubation of pAR3lux reporter-
transfected H9 cells in RecNodal (50 ng/ml) resulted in a 4-
fold induction as compared to control (P = 0.01, 4 d.f.) (Fig.
3C), and incubation in supernatant of a representative
Nodal-overexpressing hESC cell line resulted in 20-fold
induction above control level (P = 0.01, 4 d.f.) (Fig. 3C).
Therefore, functional Nodal protein is properly expressed
and secreted by hESCs. Finally, five Nodal-expressing H9
cell lines (NHN4, NHN5, NHN13, NHN14, BHN1, and
BHN2) and five Nodal-expressing hSF-6 cell lines
(NHN1hsf6, NHN4hsf6, BHN1hsf6, NodalGFP3hSF6,
and NodalGFP7hSF6) were studied to verify that the results
obtained were cell line-and clone-independent (Supplemen-
tary Figs. 1A, B). Moreover, an hrGFP-overexpressing
hESC cell line was included as a negative control with wild-
type hESCs in each of the experimental series to control for
any effects induced by the genetic manipulation procedure
itself.
These Nodal-expressing cell lines and their respective
controls were characterized as monolayer cultures for the
expression of the pluripotency markers Oct-4, Tra-1-60, and
SSEA-4 using immunofluorescence (Henderson et al.,
2002). No differences were observed as compared to wild-
type hESCs (Fig. 3D). Moreover, the hESC differentiation
marker SSEA-1 was not detected (data not shown). Gene
expression was assessed using RT–PCR, which confirmed
that Nodal-expressing hESCs expressed the same pluripo-
tency markers as wild-type cells without expressing the
markers of differentiation, Neurod1, MyoD, Myf5, IFABP,
and aFP (Supplementary Figs. 1 and 2, and data not
shown). Therefore, Nodal overexpression did not induce
primary germ layer differentiation of hESCs grown as
monolayer cultures, confirming and expanding the results
we obtained with recombinant Nodal.HNpTP6 vectors. pTP6 vector contains the CAGG promoter followed by the
on for transgene expression. (B) Screening of Nodal-expressing hESCs.
, as determined by RT–PCR. RNA from hESCs expressing a gene encoding
tive controls. h2 Microglobulin (h2M) was used as a loading control. (C)
x reporter. H9 cells were transiently transfected with the p3AR-Lux vector.
50 ng/ml of recNodal, or in presence of supernatant from a representative
expressed as the mean F SD from three informative experiments. (D)
pressing hESCs. SSEA4, Tra-1-60, and Oct-4 expression were analyzed in
rows in the left panels indicate regions with a differentiated morphology
ch areas were negative for the expression of Oct-4, Tra-1-60, and SSEA4
.
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We then investigated the development of EBs generated
from Nodal-expressing hESC by growing colonies in
suspension cultures using CDM medium. As previouslynoted, control EBs grown in CDM developed almost
entirely as homogenous spheres with no apparent tissue
organization. By contrast, the majority of Nodal-expressing
EBs (type 1) consisted of three distinct cell layers (nEB1,
Fig. 4A; and NoGFP, Fig. 4B). The outside layer (L1, Fig.
L. Vallier et al. / Developmental Biology 275 (2004) 403–4214104A) of type 1 EBs was a single, thin sheet of cells. The
inside layer (L2) consisted of cells organized into a
columnar epithelium, which strikingly resembled the epi-
blast layer of early postimplantation stage mouse embryos,whereas the central core (L3) contained rounder cells.
Several other types of Nodal-expressing EBs were also
observed, but at substantially lower frequencies. EBs with
type 2 morphology (nEB2, Fig. 4A) consisted of a single
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morphology (nEB3, Fig. 4A) developed to a more prom-
inent size, yet lacked an organized structure. EBs with type
4 morphology (nEB4, Fig. 4A) were asymmetric, having
one side that resembled the homogenous control EBs and a
distinct opposite side consisting of an outer cell layer (L1) in
contact with a columnar epithelial layer (L2) like that seen
in type 1 EBs. Finally, homogenous EBs (type 5) similar to
wild-type EBs were seen at a low frequency (nEB5, Fig.
4A). The fraction of type 1 EBs (ranging between 75% and
95%) appeared to depend on the quantity of EBs and the
size of the hESC colonies used to generate EBs. A high
density of EBs (3000 EBs/15 ml of CDM) decreased the
fraction of type 1 EBs. The use of small colonies (b30 cells)
appeared to increase the fraction of type 2 EBs. Moreover,
hESCs expressing a very low level of NodalGFP (NoGFP9,
Fig. 4B) produced a majority of EBs that were similar to
wild type (type 5), indicating that formation of type 1 EBs
depends on the level of Nodal expression. In sum, Nodal-
expressing hESCs underwent a unique developmental
program during EB formation, resulting in differentiation
of novel EB morphologies and cellular phenotypes as
compared with control EBs.
Nodal-overexpressing EBs display markers of pluripotency
and extraembryonic endoderm
We therefore undertook a molecular and immunohisto-
chemical analysis to determine the identity of cells in the
complex embryoid bodies generated by Nodal-expressing
hESC. RT–PCR analysis performed on each of the EB types
(Table 1) revealed that the pluripotency markers Oct-4,
FGF4, and Cripto continued to be expressed in types 1, 3, 4,
and 5 EBs after 10 days of differentiation, in contrast to
control EBs, which had essentially ceased expressing
pluripotency markers within 1 week of differentiation in
CDM (Fig. 2B). Oct-4 expression in Nodal-expressing EBs
was confirmed at the RNA level by in situ hybridization and
at the protein level by immunofluorescence (Figs. 4C, E).
No expression of neuroectoderm markers (Table 1, Neu-
roD1) was detected in Nodal-expressing EBs, in contrast to
control EBs, which did express them (Table 1, WT-EB).Fig. 4. Effect of Nodal overexpression on differentiation of hESCs. (A) Morpholo
during 10 days in CDM. Almost all the wild-type EBs grown in CDM were solid, h
contrast, the vast majority of Nodal-expressing EBs were organized into three la
(central core). The bottom panels show the frequency distribution of wild-type an
Scale bar: 200 Am. (B) NodalGFP protein expression in hESCs and in differentiate
clear expression of Nodal protein. Wild-type cells were used as negative control (N
(hrGFP1). Three NodalGFP-expressing cell lines (NoGFP3, NoGFP7, and NoGFP
(middle and left panel) were also organized into three layers as observed for expre
expression after 10 days of differentiation in wild-type EBs (left panel) and Nodal
was invariably detected in the inner layer (L2) of type 1 Nodal-expressing EBs (nE
Scale bar: 200 Am. (D) Analysis of H19 gene expression after 10 days of different
hybridization. Sense probe was used in the negative control (Neg) to show abs
analysis of aFP and Oct-4 expression after 10 days of differentiation in wild-type
shown by Hoechst staining (blue fluorescence). Visceral endoderm is indicated by
in Nodal-expressing EBs are shown by Oct-4 expression (pink florescence combThus, Nodal expression during EB development led to
retained expression of markers of pluripotency, while
preventing progression along the default neuroectoderm
pathway, a principal endpoint of differentiation in controls.
Nodal expression during the development of EBs did not
block differentiation altogether, as indicated by evidence for
the formation of an extraembryonic cell type. In type 1 EBs,
we detected expression by RT–PCR of a set of markers
characteristic of mouse extraembryonic endoderm, includ-
ing aFP, BMP2, GATA4, HNF3h, and HNF4 (Table 1).
Transcripts of H19, an imprinted gene strongly expressed in
extraembryonic tissues at the time of gastrulation in mouse
embryos (Poirier et al., 1991), were also detected by in situ
hybridization (Fig. 4D). In addition, the presence of aFP
protein was detected in type 1 Nodal-expressing EBs using
immunofluorescence (Fig. 4E). Type 2 Nodal-expressing
EBs also expressed a similar set of marker genes,
specifically, aFP, BMP2, HNF3h H19, HNF4, Nodal, and
GATA4 (Table 1, Fig. 4D). The only known candidate for a
tissue expressing this set of genes during early mammalian
development is the visceral endoderm (VE), which becomes
fully differentiated at the time of gastrulation in the mouse
embryo. Consistent with this, neither type 1 nor type 2
Nodal-expressing EBs expressed the definitive endoderm
marker, IFABP (Table 1). Moreover, the aFP gene was the
only member of the set of visceral endoderm markers that
was detected in the control EBs at this time of differ-
entiation, suggesting that control EBs progress only a
limited way on the pathway towards extraembryonic
endoderm (Table 1, Fig. 4E). Therefore, Nodal expression
apparently induces the differentiation of VE in the vast
majority of EBs developing from Nodal-expressing hESC.
Nodal-expressing EBs consist of an outer layer of AVE-like
cells surrounding an inner layer of epiblast-like cells that
maintain the molecular signature of pluripotency
The developmental consequences of Nodal expression
were further investigated by examining the constituent
layers of Nodal-expressing EBs. RT–PCR analysis of
microdissected tissues of type 1 EBs revealed that the
outside layer (Table 1, L1) expressed markers of visceralgy of wild-type EBs and Nodal-expressing EBs undergoing differentiation
omogenous masses of cells (typical EBs shown in the upper left panels). By
yers (upper right panels) denoted as layers L1 (outer), L2 (inner), and L3
d Nodal-expressing EBs into distinct morphological types (nEB1 to nEB5).
d EBs. FACS analysis of NodalGFP-expressing hESCs (left panel) showed a
eg), whereas an hrGFP-overexpressing cell line was used as positive control
9) of 15 generated were used for this experiment. NodalGFP-expressing EBs
ssion of NHN and BHN Nodal transgene expression. (C) Analysis of Oct-4
-expressing EBs (middle and right panels) using in situ hybridization. Oct-4
B1), but it was consistently absent from the outside layer (L1, right panel).
iation in types 1 and 2 Nodal-expressing EB (nEB1 and nEB2) using in situ
ence of nonspecific staining. Scale bar: 200 Am. (E) Immunofluorescence
(left panel) and Nodal-expressing EBs (middle and right panels). Nuclei are
aFP expression (red fluorescence, left and middle panels). Pluripotent cells
ining red Oct-4 + blue nuclear staining, right panel) Scale bar: 50 Am.
Table 1
Gene expression patterns of wild-type and Nodal-expressing EBs
Tissue Markers WTEB nEB1 nEB2 nEB3 nEB4 nEB5 L1 L2 L3
hESCs Oct-4  +  + + +  + +
FGF4  +  + + +  + +
Cripto  + + + + + nd nd nd
Ecto Neurod1 +     +   
Meso Bra  +  + + + nd nd nd
MyoD         
MyF5         
Endo IFABP         
HNF3  + + + + + + + +
VE AFP + + + + + + +  
HNF4   + +   nd nd nd
H19  + + + + + +  +
GATA4  + + + + + +  
BMP2  + + + + + nd nd nd
hNODAL  + + + + + + + +
AVE HEX  +  + + + +  
Cer  +  + + + + + +
Lhx1 + +  + + + + + +
Otx2  +  + + + + + +
The expression of markers characteristic of hESCs, ectodermal (ecto), mesodermal (meso), or endodermal (endo) germ layers, and visceral (VE) or anterior
visceral (AVE) extraembryonic endoderm was analyzed after 10 days of differentiation using RT–PCR. Results are summarized for wild-type EBs (WTEB),
nodal-expressing EB (types nEB1, nEB2, nEB3, nEB4, and nEB5), and the three layers of nEB1 (L1, L2, and L3). Expression of markers is indicated by (+).
Expression of Cripto, Brachyury (Bra), HNF4, and BMP2 was not analyzed in the three separate layers of nEB1 (indicated by nd).
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L3) expressed markers of pluripotency. Immunofluores-
cence analysis of sectioned type 1 EBs showed clearly that
aFP was expressed by the outside layer and Oct-4 by the
inside layers (Fig. 4E). H19 expression was also detected in
the outside layer by RT–PCR and in situ hybridization
(Table 1, Fig. 4D). Types 3, 4, and 5 EBs expressed a
mixture of VE and pluripotency markers (Table 1). Analysis
of Oct-4 expression in these EB types by immunofluor-
escence or by in situ hybridization showed the presence of
variable numbers of pluripotency marker-expressing cells in
the various EB types (data not shown); moreover, aFP
protein was detected in their outside layer. The presence of
both VE-like and pluripotent marker-expressing cells in
types 3, 4, and 5 EBs suggests that they represent
intermediate stages in the development of the complex,
multilayered structure of type 1 EBs.
In view of the importance of the visceral endoderm layer
in the anterior–posterior development of mammalian
embryos (reviewed by Perea-Gomez et al., 2001b), we
examined in further detail the molecular identity of the outer
layer of Nodal-expressing EBs using RT–PCR to detect the
expression of genes typically expressed in the anterior
visceral endoderm (AVE) of mouse embryos at the time of
gastrulation (Bielinska et al., 1999). The outside layer of
type 1 EBs expressed Hex, Lhx1, Cer, H19, and OTX2,
which were not expressed by control EBs (Table 1, Fig. 4D).
The most informative of these, Hex, which is a specific
marker of the AVE in gastrulating mouse embryos, was
expressed exclusively in the outer layer (Table 1). These
results show that the molecular phenotype of the VE
generated during Nodal-expressing EB development strik-ingly resembles that of the anterior visceral endoderm of
mouse embryos.
We then investigated further the nature of the inner
layers. The columnar organization of the inside layer
strikingly resembled the epiblast layer of mouse embryos.
Moreover, OTX2 was expressed in the inner layer and
central core of Nodal-expressing EBs but not in undiffer-
entiated hESCs (Table 1, Figs. 5A, B). During mouse
embryo development, OTX2 is expressed just after implan-
tation in visceral endoderm but is coexpressed with Oct-4
only in epiblast cells (Ang et al., 1994), suggesting that
OTX2-expressing cells in Nodal-expressing EBs are indeed
epiblast-like. To confirm this possibility, we examined the
expression of well-characterized marker genes for mouse
embryo development at the inner cell mass stage (GBX2;
Chapman et al., 1997), the primitive ectoderm stage (FGF5;
Rathjen et al., 1999), and the early epiblast stage (OTX2,
Ang et al., 1994) during differentiation of wild-type or
Nodal-expressing hESCs. We found that wild-type cells
expressed GBX2 but neither OTX2 nor FGF5 (Figs. 5A, B),
suggesting that they share certain transcriptional features of
mouse inner cell mass cells. FGF5 expression was induced
in wild-type EBs after 5 days of differentiation in CDM,
while Oct4 disappeared and Neurod1 started to be expressed
(Fig. 5A). GBX2 expression was maintained until day 14,
which was not unexpected, given that GBX2 is also
expressed in neuronal precursors after gastrulation (Wassar-
man et al., 1997). Thus, wild-type EBs appeared to undergo
differentiation into a primitive ectoderm-like cell type
expressing FGF5 before progressing towards a neuro-
ectoderm-like cell type expressing Neurod1. By contrast,
Nodal-expressing cells did not express FGF5 during differ-
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of AVE-like cells of type 1 Nodal-expressing EBs (Figs. 5A,
B). As expected, OTX2 was strongly expressed in the AVE
layer, but it was also detected in the two inner layers (Table
1, Fig. 5B). These data suggest that hESC differentiation is
blocked at an intermediate stage between inner cell mass
and late epiblast as a consequence of Nodal expression
during EB development in CDM. Finally, the differentiation
of epiblast-like and AVE-like cell layers in Nodal-express-
ing EBs (both striking in their resemblance to mouse
embryo cell lineages) appeared to be interdependent, as they
were consistently found to be adjacent to each other (e.g.,
types 1 and 4 EBs). This could be explained on the basis of
interactions between the AVE and epiblast layers as
previously demonstrated in mouse embryos (reviewed in
Perea-Gomez et al., 2001b), where AVE affects the
progression of epiblast differentiation.
Nodal expression blocks differentiation of hESCs grown in
adherent conditions in chemically defined medium
The developmental capacity of type 1 Nodal-expressing
EBs was examined by growing them in adherent con-
ditions, which fostered the outgrowth of their constituent
cells. The first cells emerging from the spreading EBs
within a few days of adherent culture (Fig. 5C) had a
characteristic morphology with a flat nucleus and a large
number of pinocytotic vacuoles, thereby resembling mouse
AVE (Kimura et al., 2000). The extraembryonic endoder-
mal phenotype of these cells was confirmed by the
presence of large quantities of aFP protein (Fig. 5C).
After 1 week in culture, a second cell type began to
emerge: these were round with a small amount of
cytoplasm and a large nucleus, and they grew as extensive
monolayers similar to the early primitive ectoderm cells
described by Rathjen et al. (1999) (Fig. 5C). These latter
cells, evidently derived from the epiblast-like cell layer,
expressed Oct-4 and Tra-1-60 (Figs. 5C, Supplementary
Fig. 2), and they could be grown in adherent conditions for
at least 10 passages (N50 days; data not shown). The source
of these two distinct outgrowing cell types from the AVE-
like outer layer and epiblast-like inner layer, respectively,
was confirmed by microdissection and culture of isolated
layers (data not shown). Expression of definitive neuro-
ectoderm markers (Supplementary Fig. 2: NeuroD1) and
mesoderm markers (Supplementary Fig. 2: MyoD, Myf5)
was not detected by RT–PCR in the outgrowths from Nodal-
expressing EBs, although these transcripts were seen in
outgrowths from wild-type EBs (Supplementary Fig. 2 and
data not shown). Expression of the definitive endoderm
marker IFABP (Supplementary Fig. 2) was not detected in
outgrowths from either Nodal-expressing or wild-type
plated EBs. Therefore, differentiation of Nodal-expressing
cells along each of the three definitive germ layer pathways
seemed to be blocked when they were grown in adherent
conditions.To investigate this phenomenon further, we compared
pluripotency marker gene expression in wild-type and
Nodal-expressing hESCs that were grown directly in
adherent conditions (i.e., without an EB intermediate phase)
in CDM without FGF or serum. Under these conditions,
wild-type hESCs began differentiating after the first
passage, while Nodal-expressing hESCs formed large
monolayers of cells resembling those outgrowing from type
1 Nodal-expressing EBs (data not shown; see Fig. 5C for
illustration of this phenotype). These cells expressed Oct-4,
SSEA-3, SSEA-4, and Tra-1-60 but not SSEA-1, a specific
maker for differentiated cells (Fig. 5D and data not shown).
The level of differentiation under these culture conditions
was quantified by FACS, evaluating the fraction of cells
expressing SSEA-4 or Tra-1-60 (Fig. 5D and data not
shown). After six passages, 90% of the Nodal-expressing
cells were SSEA-4-positive as compared to 17% for wild-
type cells. In parallel cultures of wild-type hESCs grown on
feeders, 95% were SSEA-4-positive. Similar results were
obtained for Tra-1-60 expression (data not shown). There-
fore, differentiation was blocked with a phenotype resem-
bling that attained in EBs when Nodal-expressing hESCs
were grown directly in adherent conditions for prolonged
periods in culture. Interestingly, alpha-fetoprotein expres-
sion was rarely detected in these culture conditions showing
that AVE-like cells were absent also suggesting that the
emergence of the AVE phenotype depends on interactions
that take place during EB development.
Nodal effects on EB development are position- and
concentration-dependent
The distinct developmental fates of cells occupying the
inner and outer regions of Nodal-expressing EBs could be
explained by two different mechanisms. On the one hand,
cells expressing different levels of Nodal could have moved
during EB development to distinct regions of the EBs to
form either the AVE-like outer layer or the epiblast-like
inner layer (cell movement hypothesis). Alternatively, cells
located on the outside of the EBs could have been induced
to differentiate into VE owing their specific location in the
EB’s outer environment (inside/outside hypothesis). To
distinguish between these two hypotheses, we mixed
Nodal-expressing hESCs with green fluorescent hESCs
(not Nodal-expressing) and then induced their differentia-
tion by EB formation. The cell movement hypothesis
predicted that Nodal-negative cells (i.e., GFP-positive cells)
would be detected mainly or exclusively in one of the
layers. This pattern was not observed, and instead green
fluorescent cells were found throughout all three layers of
type 1 EBs (nEB1, Fig. 6A). This result supports the view
that distinct cell types differentiate in Nodal-expressing EBs
as a result of their location.
Interestingly, the fraction of type 5 EBs (wild type-like)
in these mixing experiments was greatly increased at the
expense of the type 1 EB fraction (nEB1, Figs. 6A, B), just
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Apparently, the dilution of Nodal-expressing cells by
Nodal-nonexpressing cells provoked this shift in EB
morphology. Consistent with this, EBs containing predom-inately green fluorescent cells generally developed with type
5 morphology and had a large fraction of Oct-4-negative
cells (nEB5, Figs. 6A, B). However, when the type 1 EBs
that did form in this series were examined by immuno-
Fig. 5. Nodal blocks differentiation of hESCs at an early epiblast stage. (A) Examination of ICM and epiblast markers in hESCs and during differentiation
using RT–PCR. Nodal-expressing cells or wild-type cells were grown in nonadherent conditions in CDM during 14 days. RNAs were extracted from EBs every
3 days, and RT–PCR analysis was performed to detect the expression of the genes denoted. (B) Analysis of GBX2 and OTX2 expression in hESCs (left and
right top panels, respectively) and after 10 days of differentiation in Nodal-expressing EBs (bottom panels) using in situ hybridization. GBX2 was invariably
detected in the outside layer (L1) of type 1 Nodal-expressing EBs (nEB1), but it was consistently absent from the inside layer (L2, left panel). OTX2 was
expressed in the outside and inside layers (right panel). Scale bar: 100 Am. (C) Cells generated after plating of Nodal-expressing EBs. Morphology of AVE-like
cells (left panel) and hESC-like cells (right panel) after 10 days of culture in adherent conditions. AVE-like cells expressed aFP (green fluorescence, bottom lef
panel), and hESC-like cells expressed Tra-1-60 and Oct-4 (green fluorescence, middle and right bottom panels). Scale bar: 50 Am. (D) Level of differentiation
of wild-type hESCs (WT, right panel) or Nodal-expressing hESCs (NHN5, right panel) grown in adherent conditions in CDM was established using FACS to
determine the fraction of SSEA-4-expressing cells after six passages (approximately 30 days). hESCs grown on feeders layer were used as positive contro
(Pos, left panel). Similar results were obtained with five different Nodal-expressing cell lines as with epiblast-like cells outgrowing from plating of Nodal
expressing EBs.
L. Vallier et al. / Developmental Biology 275 (2004) 403–421 415fluorescence, their green fluorescent cells (between 5% and
75% of total cells) were occasionally found to express Oct-4
if they were located in the inside layers. Taken together,
these observations demonstrate that Nodal effects are
concentration-dependent and that Nodal is able to affect
neighboring cells (i.e., to act cell nonautonomously).
Moreover, it is apparent from these mixing experiments
that the Nodal generated by Nodal-expressing hESC acts
predominantly locally within the embryoid bodies instead of
by accumulating in the culture medium, since the Nodal-
nonexpressing, Oct-4-positive cells were distributed in
scattered, rather than continuous, patterns. This finding
can account for the distinct phenotypes observed when
Nodal was provided as exogenous recombinant, versus
endogenously synthesized, protein.Discussion
By treating hESCs with the TGF-h family member
Nodal, either as recombinant protein or through expression
of the mouse Nodal gene, we found that Nodal had dynamic
effects on their in vitro development as EBs. Essentially,
Nodal acted as an inducer of visceral endoderm and
maintained the expression of known markers of pluripo-
tency, two developmental outcomes that are likely to be
interrelated. To place these effects in the context of normal
mammalian development, it is worthwhile considering thet
l
-role of Nodal in early mouse embryogenesis, since human
embryos have not yet been studied in molecular detail at the
corresponding developmental stages. This comparison
illustrates the potential utility of hESCs in modeling human
embryogenesis by providing insight into the role of Nodal in
early human developmental events.
Nodal maintains expression of markers of pluripotency
during differentiation of hESCs
During mouse development, Nodal expression is first
detected just after implantation (5.5 dpc) throughout the
epiblast and at lower levels in the surrounding layer of VE
(Varlet et al., 1997). Nodal expression becomes restricted to
the posterior part of the epiblast with the approach of
gastrulation and disappears from the epiblast during
primitive streak elongation, to be detected thereafter in the
node and subsequently in the left lateral plate mesoderm
(Collignon et al., 1996). This pattern of Nodal expression
could indicate different functions for Nodal before and after
gastrulation in mammals. Nodal null mutant embryos by
themselves do not clarify this question because their growth
is arrested before primitive streak formation (Conlon et al.,
1994; Iannaccone et al., 1992; Zhou et al., 1993).
In addition to Nodal effects on axial patterning of the
gastrula and later stage embryo, several features of both
mouse embryos and hESCs suggest that Nodal signaling
could also be involved in maintenance of pluripotency at
Fig. 6. Analysis of cell–cell interaction requirement for Nodal effect on pluripotency. (A) EBs generated from mixed colonies of green fluorescent hESCs (not
Nodal-expressing) and Nodal-expressing hESCs. Left panel: type 1 EB (nEB1) generated after 10 days of differentiation showing the presence of green
fluorescent cells in all three layers (whole mount). Middle panel type 5 EB (nEB5) containing only green fluorescent cells (whole mount). Right panel,
immunofluorescence analysis of Oct-4 expression (red fluorescence) in a cryosectioned type 1 EB containing both nongreen and green fluorescent cells (nEB1)
and of a type 5 EB containing only green fluorescent cells (nEB5). Blue fluorescence shows nuclei stained with Hoechst dye; blue/green fluorescence shows
nuclei of green fluorescent protein expressing cells; pink fluorescence shows Oct-4 expression in Nodal expressing cells (red + blue); and yellow fluorescence
(white arrow) shows Oct-4 expression in green fluorescent cells (red + green). Scale bar: 50 Am. (B) Relationship between the relative abundance of green
fluorescent cells (i.e. not overexpressing Nodal) and type of morphology. Each type of EB (nEB1–nEB5) was divided into four different arbitrary categories
based on the relative amount of green fluorescent cells they contained (0%, approximately 5%, approximately 50%, approximately 100%). This experiment
was repeated three times and similar results were obtained. Thus, results were pooled, with the fraction number of EBs in each category indicated in parentheses
(number of EBs in each subclass indicated at top of histogram bars).
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display very low levels of Oct-4 expression, and the size
of the epiblast cell population is substantially reduced
(Conlon et al., 1994; Iannaccone et al., 1992; Robertson et
al., 2003). From this perspective, the pregastrulation arrest
of Nodal null mutant mouse embryos could reflect the
diminished capacity of Nodal-deficient epiblast cells for
self-renewal, rather than a blockade in the induction of
mesoderm and endoderm precursors. Thus, the absence of
posterior markers (i.e., Wnt3 and FGF8) in Nodal null
mouse embryos (Brennan et al., 2001; Robertson et al.,2003) could be understood as a consequence of diminished
pluripotency. Applied to early human development, this
hypothesis appears to be supported by our experiments,
since hESC differentiation is blocked by Nodal over-
expression, as revealed by the continued expression of
markers of pluripotency in hESC cultured with recNodal or
expressing Nodal.
While the expression pattern of Nodal and its receptor-
mediated signaling pathway are unknown in peri-implanta-
tion human embryos, the onset of Nodal expression in
mouse embryos (E5.5, specifically in epiblast) suggests a
L. Vallier et al. / Developmental Biology 275 (2004) 403–421 417unique role of Nodal in epiblast development. Consistently
with this suggestion, one prominent response to Nodal
expression in hESCs is development of a pluripotent cell
layer with striking morphological and molecular resem-
blance to epiblast. The hESC-like monolayers generated by
plating Nodal-expressing EBs also share some morpholog-
ical characteristics with mouse early primitive ectoderm
cells, in that they grow in large monolayer colonies and
have a small amount of cytoplasm, somewhat similar to the
EPL cells reported by Rathjen et al. (1999). However, such
Nodal-expressing EB-derived cells have a distinct molecular
signature from primitive ectoderm (Rodda et al., 2002), in
that they do not express FGF-5. While it remains difficult to
establish the equivalence between hESC-derived and true
embryo-derived lineages without the early human embryo
gene expression patterns for comparison, it nevertheless
appears that the epiblast-like inner (L2) layer of Nodal-
expressing EBs represents a cell type that is distinct from the
inner cell mass of blastocysts, yet has not progressed to the
onset of epiblast differentiation that accompanies gastrula-
tion. This cell type could have unique features in human
embryos, since the time between implantation and gastru-
lation is significantly longer than in the mouse.
Taken together, these results suggest that Nodal functions
to maintain pluripotency in Nodal-expressing EBs in a cell
type equivalent to the epiblast layer, or its more primitive
precursor, in the mammalian embryo before gastrulation
(Fig. 7, model A). The absence of definitive mesoderm orFig. 7. Alternative models for Nodal effects on development of the epiblast-like lay
A) Nodal maintains pluripotency through direct effects on epiblast-like and epibla
secretion of inhibitors (e.g., Cerberus, Lefty) of mesoderm and endoderm differen
on epiblast-like and epiblast cells. The net effect in either case is maintenanc
Comparable mechanisms in mouse embryos would lead to maintenance of epibl
epiblast (model B). Ant indicates anterior; Post, posterior; VE, visceral endodermendoderm differentiation in Nodal-treated or Nodal-express-
ing hESCs seems to be in contradiction with results obtained
in chick (Bertocchini and Stern, 2002), Xenopus (Jones et
al., 1995), zebrafish (Erter et al., 1998), and in mouse
(Perea-Gomez et al., 2002) embryos, where Nodal gain of
function enhances mesendoderm development. However,
those experiments were done during gastrulation in vivo,
where additional growth factors (e.g., BMP-4, Wnt-3, FGF-
4, -5, -8) that could synergize with Nodal are also present.
The chemically defined medium used in the present study,
by contrast, contains only factors produced by the cells
themselves and so might not be sufficient to provoke
mesendoderm differentiation. However, when Nodal-
expressing EBs were cultured in medium containing FBS,
which should provide additional factors needed for differ-
entiation, they continued to express markers of pluripotency
(data not shown). Therefore, promotion of pluripotency,
rather than definitive germ layer differentiation, appeared to
be the dominant consequence of Nodal expression in the
hESC system. It should be noted that Nodal may have
different consequences for each particular stage of epiblast
development, in which case the intermediate stage appa-
rently formed by Nodal-expressing EBs could be less
responsive to Nodal-induced mesoderm and endoderm
differentiation than epiblast cells at the threshold of
gastrulation.
Our findings of Nodal-induced maintenance of pluripo-
tency could reflect either the direct action of Nodal oner of Nodal-expressing EBs and the epiblast cells of mouse embryos. (Model
st cells. (Model B) Nodal-induced differentiation of AVE-like cells leads to
tiation; Nodal prevents neuroectoderm differentiation through direct effects
e of pluripotency by epiblast-like cells of Nodal-expressing hESC EBs.
ast pluripotency (model A) or polarized anterior–posterior development of
; AVE, anterior visceral endoderm.
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mechanism in which pluripotency is maintained through
Nodal-induced differentiation of extraembryonic tissues.
Nodal induction of AVE-like differentiation and its potential
for inhibition of mesoderm and endoderm differentiation
Nodal expression by hESC during EB development
induces the differentiation of an outer layer of AVE-like
cells, as evidenced by expression of the AVE markers Hex,
Cer, and OTX2 (Ang et al., 1994; Shawlot et al., 1998;
Thomas et al., 1998). While these markers are also
expressed in the anterior definitive endoderm of mouse
embryos, the outer cells of Nodal-expressing EBs homoge-
nously express aFP and H19, two distinctive markers of
extraembryonic endoderm in the mouse (Krumlauf et al.,
1985; Poirier et al., 1991). Thus, Nodal signaling appears to
be sufficient to initiate and sustain the differentiation of an
AVE-like phenotype.
Previous studies on mouse embryos have revealed an
essential function for Nodal in differentiation of the AVE
and, through it, on anterior–posterior patterning. Chimeric
analysis using wild-type mouse ES cells to rescue Nodal
mutant mouse embryos has demonstrated that absence of
Nodal expression in prospective VE induces truncation of
the anterior regions (Varlet et al., 1997). Moreover,
hypomorphic mutations and deletions of specific enhancers
within the regulatory region of the Nodal gene allow
development to proceed through gastrulation and reveal
the distinct roles of early and later phases of Nodal signaling
(Lowe et al., 2001; Norris et al., 2002; Robertson et al.,
2003). Those studies show that expression of Nodal in
mouse embryos is needed not only for initiation of
gastrulation, but also for the normal development of the
VE, notably for the stereotypic anterior movement of the VE
that precedes and accompanies gastrulation and is necessary
for acquisition of anterior–posterior polarity (Yamamoto et
al., 2004; reviewed in Perea-Gomez et al., 2001b). These
and other developmental consequences of Nodal expression
are highly dose-dependent, as revealed by the different
spectrum of phenotypes depending on the level of Nodal
actually produced (Lowe et al., 2001; Norris et al., 2002).
It is well established that AVE and anterior definitive
endoderm (ADE) of the mouse embryo secrete factors that
inhibit the function of posteriorizing signals (reviewed in
Perea-Gomez et al., 2001b). Cerberus and Lefty are the
principal inhibitors of Nodal function that are known to act
during gastrulation (Belo et al., 1997; Meno et al., 1999).
Double mutants for these two genes develop several
primitive streaks; nevertheless, they also express neuronal
markers, so the AVE does not appear to act as an inhibitor of
neuroectoderm development (Perea-Gomez et al., 2002).
Germ layer explant assays combining ectoderm and VE
have also shown that mouse AVE is capable of acting as an
inhibitor of posteriorizing signals (Kimura et al., 2000). The
strength of evidence in support of an AVE-dependentmechanism for inhibition of posteriorizing signals leads us
to postulate that the presence of an AVE-like layer
surrounding Nodal-expressing EBs contributes to blocking
the induction of mesoderm and endoderm differentiation.
However, maintenance of pluripotency markers cannot be
explained by this mechanism alone. This is because the
neuroectoderm default model (reviewed in Munoz-Sanjuan
and Brivanlou, 2002) applies to the hESC system and
should thus lead the inner cells of Nodal-expressing EBs to
adopt a neuroectoderm fate even in the presence of AVE.
Since this was not observed, Nodal would appear to act
directly either to maintain pluripotency or to inhibit neuro-
nal differentiation (Fig. 7, model B). Such a mechanism
would be in agreement with the recent model of pluripo-
tency proposed by Ying et al. (2003) for mouse ES cells,
postulating that self-renewal is the result of two distinctive
differentiation-inhibiting signals, one preventing mesendo-
derm formation and another neuroectoderm.
The possibility that Nodal is able to inhibit neuronal
differentiation is supported by the null mutation of the
transcriptional corepressor Drap1 (Iratni et al., 2002), which
induces abnormal expression of Nodal in the anterior part of
the embryo before gastrulation, blocks expression of
anterior neuroectoderm markers, and causes ectopic expres-
sion of posterior markers. Thus, it appears likely that Nodal
function can directly interfere with neuroectoderm develop-
ment at early stages of development (i.e., before primitive
streak formation). In exploring this hypothesis, we gener-
ated multiple hESC lines stably overexpressing either Lefty
(n = 24) or Cerberus-Short (n = 32) (L. Vallier and R.A.
Pedersen, unpublished observations). Preliminary examina-
tion of representative lines shows that such inhibition of
Nodal function in these lines does not provoke hESC
differentiation, suggesting that Nodal acts jointly with other
factor(s) in maintaining pluripotency. TGFh1 and Activin
are potential candidates, since they can both activate the
same signaling pathway as Nodal. Intriguingly, these Lefty-
and Cerberus-Short-expressing hESC lines underwent
extensive neuroectodermal development, consistent with
our findings on Nodal gain-of-function in which neurecto-
derm development was inhibited. Further experiments
analyzing the TGFh signaling pathway at the molecular
level in hESCs will provide essential details on mechanisms
involving Nodal both in maintaining pluripotency and
inhibiting neural development.
Taken together with mouse loss-of-function studies, our
findings lead to the view (Fig. 7) that the posterior region of
the mammalian embryo, with its posteriorly localized
expression of Nodal (and other factors), acts to inhibit
anterior patterning reciprocally to the AVE and ADE (with
their inhibitory effect on posterior patterning). Further in
vivo experiments with mouse embryos will be needed to
evaluate this hypothesis.
The potential for clinical applications of hESCs is
promising, and thus the control of their differentiation is a
major focus of current stem cell research. Because hES cells
L. Vallier et al. / Developmental Biology 275 (2004) 403–421 419are capable of undergoing differentiation into the primary
germ layers and their derivatives, they also represent a
unique in vitro model to study the earliest events in human
development. Despite the limitations imposed by the
absence of data from corresponding stages of human
embryos, the comparison of our findings with the intact
mouse embryo provides evidence for the potential value of
this approach. Our results showing Nodal-induced AVE
differentiation may indicate that this extraembryonic lineage
is involved in anterior–posterior patterning in human
development through similar mechanisms as it is in the
mouse. Thus, a combination of hESC and animal modeling
can provide a powerful approach for understanding
molecular mechanisms regulating the first events of differ-
entiation during gastrulation in mammals, including
humans. In turn, such studies will lead to the design of
novel strategies for directing differentiation of hESCs into
fully functional cell types, thus revealing their potential for
clinical application.Acknowledgments
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